Skip to content

Mitochondrial Complex I Deficiency Nuclear Type 15 C4748778

Published: July 22, 2026Updated: August 25, 2026

A genetic mitochondrial disease affecting the first complex of the cellular energy production system. It can cause problems with organs requiring lots of energy. Treatment aims to manage symptoms and support metabolism.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Developmental delay

(developmental)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Muscle weakness

(musculoskeletal)

Renal tubular dysfunction

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neurodevelopmental surveillance

Regular neurological examinations and developmental assessments to track cognitive and motor progression and identify needs for early intervention services.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Branched-chain amino acid modification

Dietary management through careful protein intake balancing to reduce metabolic stress on affected mitochondrial pathways.

dietary

Additional treatment options

Developmental therapy services

Early intervention with occupational and speech therapy to maximize neurodevelopmental potential and address motor and communication delays.

procedure

Neuropsychological support

Cognitive assessment and intervention planning to address learning disabilities, attention difficulties, and behavioral concerns associated with mitochondrial encephalopathy.

psychological

Energy conservation techniques

Teaching patients pacing strategies and energy conservation methods to manage fatigue and prevent post-exertional malaise.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Mitochondrial Complex I Deficiency Nuclear Type 15 C4748778?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Mitochondrial Complex I Deficiency Nuclear Type 15 C4748778. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy